RecruitingNot ApplicableNCT06183359

Self-Identification Program

Correct Self-identification Program in the Treatment of Depression: a Randomized Controlled Trial


Sponsor

University Hospital, Montpellier

Enrollment

86 participants

Start Date

Aug 27, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Conduct a pilot, single-center, randomized controlled 2-arm study aimed to evaluate the impact of an in-depth 3rd wave CBT program targeting correct self-identification (3rd level of 3rd wave CBT), compared to a control group receiving an acceptance and commitment therapy (ACT; (1st level of 3rd wave CBT, a well-known psychotherapy). Main judgment criteria : Therapeutic response (reduction ≥ 50% between pre and immediate post-treatment), and rate of relapse at 6 months post-therapy. Secondary objectives: Evaluate psychological processes involved in the reduction of moral pain, diligence, ruminations, suicidal ideas, self-concept and alterations in functioning (mental and social), psychological skills.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study, called the Self-Identification Program, tests a psychological intervention designed to help people with a current major depressive episode understand and relate to themselves in healthier ways. Depression often involves harsh self-criticism and distorted self-perception, and this program aims to address those patterns. **You may be eligible if...** - You are between 18 and 70 years old - You are experiencing a current major depressive episode as part of unipolar or bipolar depressive disorder (diagnosed by DSM-5 criteria) **You may NOT be eligible if...** - You have a psychotic disorder (such as schizophrenia) - You have active suicidal thoughts with intent to act on them (high suicidality) - You are unable to provide informed consent - Your depressive episode is part of another primary diagnosis not covered by the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSIP

compare the SIP group versus the ACT group


Locations(1)

CHU Montpellier

Montpellier, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06183359


Related Trials